BD Biosciences to Present at Investor Healthcare Conferences
Published: Feb 13, 2012
FRANKLIN LAKES, N.J., Feb. 10, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2012:
Leerink Swann 2012 Global Healthcare Conference
February 15, 2012
10:30 a.m. ET
Citi 2012 Global Healthcare Conference
February 28, 2012
10:00 a.m. ET
Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days after each conference.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
Monique N. Dolecki, Investor Relations 201-847-5378
Colleen T. White, Corporate Communications 201-847-5369
SOURCE BD (Becton, Dickinson and Company)